US Stock MarketDetailed Quotes

INAB In8bio

Watchlist
  • 0.291
  • -0.032-10.00%
Close Feb 14 16:00 ET
  • 0.290
  • -0.001-0.28%
Post 20:01 ET
21.08MMarket Cap-0.39P/E (TTM)

About In8bio Company

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.

Company Profile

SymbolINAB
Company NameIn8bio
Listing DateJul 30, 2021
Issue Price10.00
Founded2016
CEOMr. William Ho
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address350 5th Avenue,Suite 5330
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10118
Phone1-646-600-6438
Websitehttp://www.in8bio.com

Company Executives

  • Name
  • Position
  • Salary
  • William Ho
  • Director, President and Chief Executive Officer
  • 1.85M
  • Patrick McCall
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • 914.84K
  • Dr. Lawrence Lamb, PhD
  • Executive Vice President and Chief Scientific Officer
  • --
  • Dr. Kate Rochlin, PhD
  • Chief Operating Officer
  • --
  • Alan S. Roemer
  • Chairman of the Board
  • 256.42K
  • Dr. Jeremy Graff, PhD
  • Director
  • 211.18K
  • Dr. Corinne Epperly, PhD
  • Director
  • 48.87K
  • Emily Wang Fairbairn
  • Independent Director
  • 172.92K
  • Peter C. Brandt
  • Independent Director
  • 195.42K
  • Luba Greenwood
  • Independent Director
  • 181.42K
  • Travis Whitfill
  • Independent Director
  • 163.67K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?